GlaxoSmithKline PLC Director/PDMR Shareholding (9419U)
17 Luglio 2018 - 5:54PM
UK Regulatory
TIDMGSK
RNS Number : 9419U
GlaxoSmithKline PLC
17 July 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 12
July 2018 on ADSs held in the Company's
US Deferred Performance Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$41.75 5.992
----------
$41.75 388.800
----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
394.792
$41.75
=== ======================== ===============================================
e) Date of the transaction 2018-07-12
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XYNS)
transaction
=== ======================== ===============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEDLFFVDFEBBB
(END) Dow Jones Newswires
July 17, 2018 11:54 ET (15:54 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024